ClinicalTrials.govpublic full text
T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
relapsed b-cell acute lymphoblastic leukemia, t cell immunotherapy, cd19 targeted therapy, chimeric antigen receptor (car) modified t cells, conditioning chemotherapy, 13-052, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851126
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.